ACTG1 and cardiac hypertrophy: Wu et al. discovered that circYAP, downregulating in the heart samples of patients with cardiac hypertrophy, can bind with Tropomyosin-4 (TMP4) and gamma-actin (ACTG) to limit actin polymerization, therefore preventing myocardial fibrosis [47].